Currency
Biotin-labeled Goat Anti-Rabbit IgG(H+L)

Biotin-labeled Goat Anti-Rabbit IgG(H+L)

€ 95,00

Biotin-labeled Goat Anti-Rabbit IgG (H+L) is a high-purity and high-specificity secondary antibody
for Western, ELISA, IHC, ICC, immunofluorescence, flow cytometry assays etc.

Package: 1 ml

SKU: A0277
Category: , ,

Description

Source Applications WB/ELISA IHC/IC IF/F
Goat WB, ELISA, IHC, ICC, IF, F 1:1000-3000 1:50-500 1:500-2000

 

WB, Western blot; IHC, Immunohistochemistry;
ICC, Immunocytochemistry; IC, Immunofluorescence;
IF, Flow cytometry.

Biotin-labeled Goat Anti-Rabbit IgG (H+L) is a high-purity and high-specificity secondary antibody
for Western, ELISA, IHC, ICC, immunofluorescence, flow cytometry assays etc.

The Biotin-labeled Goat Anti-Rabbit IgG (H+L) can be detected using the HRP/AP-labeled Streptavidin
by colorimetric or chemiluminescent reactions.

This high-quality secondary antibody is obtained by immunizing goats with purified rabbit IgG,
followed by affinity purification from antiserum and adsorption to human, mouse, and rat IgG.
It has minimal cross-reactivity to human, mouse, and rat serum proteins.

The recommended dilution factors of this product for various applications are shown in the table above.
However, the dilution factor can be optimized for different antigens and primary antibodies.

This product allows for 100 routine Western blots when 10 ml of this product diluted at 1:1000
is used for each blot.

Packing List:

Item Component Quantity
A0277 Biotin-labeled Goat Anti-Rabbit IgG (H+L) 1ml
Manual – 1 copy

 

Storage Conditions:

Store at -20 °C, stable for up to 1 year.

Precautions:

This product is for R&D only. Not for drug, household, or other uses.

For your safety and health, please wear a lab coat and disposable gloves during the operation.

Additional information

Weight 2 kg
Dimensions 20 × 20 × 20 cm

Instruction

Instructions for Use：

1. Please refer to relevant experimental procedures for Western blot, ELISA, and IHC assays. The recommended dilution factor of this product in this manual for different applications can be used as a start.

Product files

MSDS

https://scandicbiotech.com/wp-content/uploads/2026/04/A0277-1006.pdf

References

Related papers：

1. Miao Sun, Bo Sun, Shicong Qiao, Xiaoling Feng, Yan Li, Shuwen Zhang, Yuhan Lin, Lihui Hou
.
Fertil Steril. 2020 Jun;113(6):1275-1285.e2. doi: 10.1016/j.fertnstert.2020.02.005. (IF 6.312)
2. Weiwei Xia, Yuanyuan Li, Mengying Wu, Qianqian Jin, Qian Wang, Shuzhen Li, Songming Huang, Aihua Zhang, Yue Zhang, Zhanjun Jia
.
Cell Death Dis. 2021 Feb 1;12(2):139. doi: 10.1038/s41419-021-03431-2. (IF 6.304)
3. Li GC, Qin XL, Song HH, Li YN, Qiu YY, Cui SC, Wang YS, Wang H, Gong JL
.
J Cell Physiol. 2019 Dec 234(12):22331-22342. (IF 5.546)
4. Ruilian Li, Fangyan Jia, Kaixuan Ren, Mai Luo, Xiaoyun Min, Shengxiang Xiao, Yumin Xia
.
J Cell Physiol. 2021 Jan;236(1):249-259. doi: 10.1002/jcp.29838. (IF 5.546)
5. Leying Chen, Zhaoyu Wu, Linan Yang, Yuyun Chen, Wenhong Wang, Liting Cheng, Chong Li, Dazhao Lv, Liangyong Xia, Jia Chen, Lina Tang, L I Zhang, Shiyi Zhang, Jie Luo
.
Transl Res. 2022 Jul:245:82-98. doi: 10.1016/j.trsl.2022.02.004. (IF 5.411)
6. Shilong Liu, Bin Li, Jianyu Xu, Songliu Hu, Ning Zhan, Hong Wang, Chunzi Gao, Jian Li, Xiangying Xu
.
Front Cell Dev Biol. 2020 Apr 23;8:213. doi: 10.3389/fcell.2020.00213. (IF 5.201)
7. Mengying Wu, Weiwei Xia, Qianqian Jin, Anning Zhou, Qian Wang, Shuzhen Li, Songming Huang, Aihua Zhang, Yue Zhang, Yuanyuan Li, Zhanjun Jia
.
Front Cell Dev Biol. 2021 Oct 21;9:754134. doi: 10.3389/fcell.2021.754134. (IF 5.201)
8. Qian Yang, Wenting Cai, Huizi Jin, Tianyi Shen, Jing Yu
.
Oxid Med Cell Longev. 2022 Aug 12:2022:1497813. doi: 10.1155/2022/1497813. (IF 5.076)
9. Dong HS, Li L, Song ZH, Tang J, Xu B, Zhai XW, Sun LL, Zhang P, Li ZB, Pan QJ, Shi QH, Shen W.
.
Theriogenology. 2009 Jul 15;72(2):219-31. (IF 2.094)
10. Wang LL, Shi DL, Gu HY, Zheng MZ, Hu J, Song XH, Shen YL, Chen YY.
.
Mol Med Rep. 2016 May;13(5):4051-7. (IF 2.1)
11. Ma CY, Yin L.
.
Neural Regen Res. 2016 Jul;11(7):1102-7. (IF 3.171)
12. Li G, Jia J, Ji K, Gong X, Wang R, Zhang X, Wang H, Zang B.
.
Int J Mol Med. 2016 Sep;38(3):767-75. (IF 3.098)
13. Tang X, Li X, Li Z, Liu Y, Yao L, Song S, Yang H, Li C.
.
TUMOR BIOL . 2016 Oct;37(10):13425-13433. (IF 3.65)
14. Liu L, Zuo Z, Lu S, Liu A, Liu X.
.
Iran J Basic Med Sci. 2017 Jul;20(7):813-821. (IF 2.146)
15. Zeng X, Chen S, Gao Q, Zong W, Jiang D, Zeng G, Zhou L, Chen L, Luo W, Xiao J, Xiao B, Ouyang D, Hu K.
.
Epilepsy Res. 2017 Dec;138:62-70. (IF 2.208)
18. Wang Y, Ren K, Xie L, Sun W, Liu Y, Li S
.
Biomed Res Int. 2018 Apr 4;2018:7272485. (IF 2.276)
19. Teng L, Chen Y, Cao Y, Wang W, Xu Y, Wang Y, Lv J, Li C, Su Y
.
Oncol Lett. 2018 May;15(5):6967-6974. (IF 2.311)
21. Yang S, Xing L, Gu L, Cheng H, Feng Y, Zhang Y
.
BASIC CLIN PHARMACOL. 2018 Aug;123(2):137-146. (IF 2.651)
22. Tan S, Wang K, Sun F, Li Y, Gao Y
.
Mol Med Rep. 2018 Aug;18(2):1305-1310. (IF 2.1)
24. Wei Q, Liang X, Peng Y, Yu D, Zhang R, Jin H, Fan J, Cai W, Ren C, Yu J
.
DRUG DES DEV THER. 2018 Sep 4;12:2715-2730. (IF 3.216)
26. Li B, Feng XJ, Hu XY, Chen YP, Sha JC, Zhang HY, Fan HG
.
Brain Res Bull. 2018 Oct;143:9-18. (IF 3.37)
28. Wang Y, Hai B, Ai L, Cao Y, Li R, Li H, Li Y
.
Iran J Basic Med Sci. 2018 Dec;21(12):1238-1244. (IF 2.146)
29. Zhong L, Liu H, Zhang W, Liu X, Jiang B, Fei H, Sun Z
.
Exp Ther Med. 2018 Dec;16(6):4951-4958. (IF 1.785)
30. Shao L, Liu Y, Xiao J, Wang Q, Liu F, Ding J
.
Int J Mol Med. 2019 Feb 43(2):761-770. (IF 3.098)
31. Li J, Wang L, Qiu Z, Su Y
.
Oncol Lett. 2019 Mar 17(3):2763-2769. (IF 2.311)
32. Xueyun Chen, Shu Chen, Weidi Liang, Fang Ba
.
Biomed Res Int. 2019 Mar 5;2019:1431760. doi: 10.1155/2019/1431760. (IF 2.276)
33. Zhao J, Meng M, Zhang J, Li L, Zhu X, Zhang L, Wang C, Gao M
.
Mol Med Rep. 2019 Apr 19(4):3168-3178. (IF 2.1)
34. Xing Y, Ren S, Ai L, Sun W, Zhao Z, Jiang F, Zhu Y, Piao D
.
Int J Oncol. 2019 May 54(5):1691-1703. (IF 3.899)
35. Lu L, Li J, Le Y, Jiang H
.
Acta Histochem. 2019 Aug 121(6):695-703. (IF 2.107)
37. Man X, Liu T, Jiang Y, Zhang Z, Zhu Y, Li Z, Kong C, He J
.
ONCOTARGETS THER. 2019 Aug 9 12:6309-6322. (IF 3.337)
39. Yan S, Liu H, Liu Z, Peng F, Jiang F, Li L, Fu R
.
CANCER MED-US. 2020 Jan 9(2):737-744. (IF 3.491)
40. Siyang Yan, Hui Liu, Zhaoyun Liu, Fengping Peng, Fengjuan Jiang, Lijuan Li, Rong Fu
.
CANCER MED-US. 2020 Jan;9(2):737-744. doi: 10.1002/cam4.2608. (IF 3.491)
41. Jiansheng Huang, Dudan Lu, Tianxin Xiang, Xiaoping Wu, Shanfei Ge, Yue Wang, Jiaxin Wang, Na Cheng
.
Oncol Lett. 2020 Apr;19(4):3173-3180. doi: 10.3892/ol.2020.11431. (IF 2.311)
42. Xiangxiang Xu, Huajun Yu, Linxiao Sun, Chenlei Zheng, Yunfeng Shan, Zhenxu Zhou, Cheng Wang, Bicheng Chen
.
Mol Med Rep. 2020 Apr;21(4):1833-1840. doi: 10.3892/mmr.2020.10995. (IF 2.1)
43. Yongxiang Xie, Fang Lan, Jie Zhao, Wei Shi
.
Int Immunopharmacol. 2020 Apr;81:106249. doi: 10.1016/j.intimp.2020.106249. (IF 3.943)
44. Chunyan Wang, Jingwei Cao, Shurong Duan, Ran Xu, Hongli Yu, Xin Huo, Yuanyuan Qian
.
J STROKE CEREBROVASC . 2020 May;29(5):104748. doi: 10.1016/j.jstrokecerebrovasdis.2020.104748. (IF 1.598)
45. Jingzan Wei, Yanyan Zhao
.
Front Pharmacol. 2020 Jul 15;11:1030. doi: 10.3389/fphar.2020.01030. (IF 4.225)
46. Wei Lian, Wensheng Chen
.
DRUG DES DEV THER. 2020 Aug 19;14:3385-3391. doi: 10.2147/DDDT.S256450. (IF 3.216)
47. Dongjian Ying, Xinhua Zhou, Yi Ruan, Luoluo Wang, Xiang Wu
.
Biochem Cell Biol. 2020 Aug;98(4):474-483. doi: 10.1139/bcb-2019-0331. (IF 2.46)
48. Shu Yang, Qian Long, Min Chen, Xiao Liu, Hang Zhou
.
Oncol Lett. 2020 Sep;20(3):2338-2346. doi: 10.3892/ol.2020.11775. (IF 2.311)
49. Zhiqiang Qu, Fengxiang Zhang, Weiwei Chen, Tao Lin, Yongming Sun
.
Exp Ther Med. 2020 Oct;20(4):3661-3668. doi: 10.3892/etm.2020.9088. (IF 1.785)
50. Hanxiang Zhang, Peng Wang, Xiang Zhang, Wenrui Zhao, Honglei Ren, Zhenming Hu
.
Mol Med Rep. 2020 Nov;22(5):4163-4172. doi: 10.3892/mmr.2020.11498. (IF 2.1)
51. Qin Li, Yan Ma, Xiao-Lu Liu, Li Mu, Bai-Cheng He, Ke Wu, Wen-Juan Sun
.
Oncol Rep. 2020 Nov;44(5):2093-2107. doi: 10.3892/or.2020.7745. (IF 3.417)
52. Liheng Li, Ke He, Siliang Chen, Wenjiang Wei, Zuofu Tian, Yinghong Tang, Chengjiang Xiao, Guoan Xiang
.
ONCOTARGETS THER. 2020 Dec 31;13:13315-13327. doi: 10.2147/OTT.S262408. (IF 3.337)
53. Di Lu, Lingling Sun, Zhengjun Li, Zhen Mu
.
Mol Med Rep. 2021 Jan;23(1):76. doi: 10.3892/mmr.2020.11714. (IF 2.1)
54. Qiumei Shi, Wuying Lang, Shiyong Wang, Guangyu Li, Xue Bai, Xijun Yan, Haihua Zhang
.
Int J Mol Med. 2021 Jan;47(1):243-255. doi: 10.3892/ijmm.2020.4769. (IF 3.098)
55. Fangrui Lin, Chenshuang Zhang, Yanping Li, Junshuai Yan, Yunjian Xu, Ying Pan, Rui Hu, Liwei Liu, Junle Qu
.
Biomed Opt Express. 2021 Feb 2;12(3):1195-1204. doi: 10.1364/BOE.415456. (IF 3.921)
56. Qian Sun, Cheng Zeng, Li Du, Chong Dong
.
Exp Ther Med. 2021 Mar;21(3):190. doi: 10.3892/etm.2021.9622. (IF 1.785)
57. Mengyang Yan, Haochen Wang, Yu Gu, Xin Li, Luyang Tao, Peirong Lu
.
Exp Eye Res. 2021 Apr;205:108521. doi: 10.1016/j.exer.2021.108521. (IF 3.011)
58. Qiang Zheng, Zhenning Liu, Haitao Shen, Xiao Hu, Min Zhao
.
Respir Physiol Neurobiol. 2021 Apr;286:103600. doi: 10.1016/j.resp.2020.103600.
59. Shan-Shan Li, Ling-Ling Xie, Zhuang-Zhuang Li, Yong-Jian Fan, Man-Man Qi, Yan-Guo Xi
.
Neurosci Lett. 2021 May 1;752:135842. doi: 10.1016/j.neulet.2021.135842. (IF 2.274)
60. Yuan-Cai Zheng, Yi-Ling Feng, Yi-Hong Wang, Li-Jun Kong, Ming-Shi Zhou, Min-Min Wu, Cheng-Yang Liu, Hua-Chun Weng, Hong-Wei Wang
.
Mol Med Rep. 2021 May;23(5):376. doi: 10.3892/mmr.2021.12015. (IF 2.1)
61. Xiaohui Xu, Yong Wu, Ke Yi, Yan Hu, Weiqun Ding, Chungen Xing
.
Int J Mol Med. 2021 Jun;47(6):104. doi: 10.3892/ijmm.2021.4937. (IF 3.098)
63. Lijun Kong, Hewei Zhang, Chaosheng Lu, Keqing Shi, Hongjian Huang, Yushu Zheng, Yongqiang Wang, Dan Wang, Hongwei Wang, Wei Huang
.
Front Pharmacol. 2021 Aug 31;12:724514. doi: 10.3389/fphar.2021.724514. (IF 4.225)
64. Dongyan Cai, Na Li, Linfang Jin, Xiaowei Qi, Dong Hua, Teng Wang
.
Front Mol Biosci. 2021 Aug 4;8:727864. doi: 10.3389/fmolb.2021.727864. (IF 4.188)
65. Yanshe Xie, Guangbin Liu, Xupeng Zang, Qun Hu, Chen Zhou, Yaokun Li, Dewu Liu, Linjun Hong
.
Cells. 2021 Sep 3;10(9):2308. doi: 10.3390/cells10092308. (IF 4.366)
66. Rongcai Ye, Chunlong Yan, Huiqiao Zhou, Yuanyuan Huang, Meng Dong, Hanlin Zhang, Xiaoxiao Jiang, Shouli Yuan, Li Chen, Rui Jiang, Ziyu Cheng, Kexin Zheng, Qiaoli Zhang, Wanzhu Jin
.
Front Endocrinol (Lausanne). 2021 Oct 14;12:744628. doi: 10.3389/fendo.2021.744628.
67. Yu Lei, Jianfei Xu, Mengju Li, Ting Meng, Meihua Chen, Yongfeng Yang, Hongda Li, Tao Zhuang, Junli Zuo
.
Front Endocrinol (Lausanne). 2021 Nov 10;12:748216. doi: 10.3389/fendo.2021.748216.
68. Hua-Chun Weng, Xin-Yu Lu, Yu-Peng Xu, Yi-Hong Wang, Dan Wang, Yi-Ling Feng, Zhang Chi, Xiao-Qing Yan, Chao-Sheng Lu, Hong-Wei Wang
.
Mol Med. 2021 Nov 13;27(1):147. doi: 10.1186/s10020-021-00408-x. (IF 4.096)
69. Pan Liu, Zhengdong Zhang, Jinwu Wang, Xiao Zhang, Xiaoping Yu, Yao Li
.
Bioengineered. 2021 Dec;12(2):9356-9366. doi: 10.1080/21655979.2021.2001240. (IF 2.205)
70. Xiaodan Li, Xiaolei Yao, Haiqiang Xie, Guomin Zhang, Mingtian Deng, Kaiping Deng, Xiaoxiao Gao, Yongjin Bao, Kang Li, Feng Wang
.
Theriogenology. 2021 Dec;176:149-162. doi: 10.1016/j.theriogenology.2021.09.026. (IF 2.094)
71. Ming-Yue Li, Xiao-Hong Dai, Xue-Ping Yu, Wei Zou, Wei Teng, Peng Liu, Xin-Yang Yu, Qi An, Xin Wen
.
J Mol Neurosci. 2022 Jan;72(1):82-96. doi: 10.1007/s12031-021-01890-y. (IF 2.678)
72. Lingfang Wang, Jian Zhang, Yingfeng Su, Yasen Maimaitiyiming, Siqi Yang, Zhangjin Shen, Shitong Lin, Shizhen Shen, Guankai Zhan, Fenfen Wang, Chih-Hung Hsu, Xiaodong Cheng
.
Front Oncol. 2022 Feb 25:12:786266. doi: 10.3389/fonc.2022.786266. (IF 4.848)
73. Ping An, Xiao-Chun Zhao, Man-Jia Liu, Yu-Qing You, Jing-Ya Li
.
Neurochem Int. 2022 Feb:153:105276. doi: 10.1016/j.neuint.2022.105276. (IF 3.881)
74. Yongjie Xiong, Jing Li, Shaojun He
.
Biol Trace Elem Res. 2022 Feb;200(2):728-739. doi: 10.1007/s12011-021-02673-7. (IF 2.639)
75. Fucun Zhu, Yi Zhong, Huan Ji, Ran Ge, Lu Guo, Haiyang Song, Heming Wu, Pengfei Jiao, Sheng Li, Chenxing Wang, Hongming Du
.
J Anat. 2022 Feb;240(2):398-409. doi: 10.1111/joa.13560. (IF 2.013)
76. Jiani Xu, Yan Zhou, Jianshui Yang, Yayun Gu, Erbao Zhang, Wenwen Yuan, Cheng Wang, Guangfu Jin, Hongxia Ma, Zhibin Hu
.
Gene. 2022 Mar 1:813:146115. doi: 10.1016/j.gene.2021.146115. (IF 2.984)
77. Qi Li, Xiaoling Qin, Xiaotong Kou, Jingyu Li, Zhongsha Li, Chang Chen
.
Exp Ther Med. 2022 Apr;23(4):282. doi: 10.3892/etm.2022.11211. (IF 1.785)
78. Guoen Cai, Fabin Lin, Dihang Wu, Chenxin Lin, Huiyun Chen, Yicong Wei, Huidan Weng, Zhiting Chen, Minxia Wu, En Huang, Zucheng Ye, Qinyong Ye
.
Front Pharmacol. 2022 May 16:13:859978. doi: 10.3389/fphar.2022.859978. (IF 4.225)
79. Qi Liu, Zixu Wang, Jing Cao, Yulan Dong, Yaoxing Chen
.
Antioxidants (Basel). 2022 Jun 22;11(7):1218. doi: 10.3390/antiox11071218.
80. Daojiang Yu, Yahui Feng, Zhiqiang Jiang, Tao Yan, Kai Fang, Yuhong Shi, Jie Zhang, Shuyu Zhang
.
Exp Ther Med. 2022 Jul 12;24(3):566. doi: 10.3892/etm.2022.11503. (IF 1.785)
81. Zhi-Bin Dong, Yu-Jia Wang, Wen-Jun Wan, Ji Wu, Bo-Jun Wang, Hai-Li Zhu, Min Xie, Ling Liu
.
Exp Ther Med. 2022 Jul 21;24(3):586. doi: 10.3892/etm.2022.11523. (IF 1.785)
82. Jiayu Yu, Tianlong Liu, Zihao Gao, Runbang Liu, Zixu Wang, Yaoxing Chen, Jing Cao, Yulan Dong
.
Nutrients. 2022 Jul 30;14(15):3164. doi: 10.3390/nu14153164. (IF 4.546)
83. Ge Yan, Xinyu Wang, Yeli Fan, Jianhan Lin, Junjie Yan, Lizhen Wang, Donghui Pan, Yuping Xu, Min Yang
.
Mol Pharm. 2022 Oct 3;19(10):3632-3639. doi: 10.1021/acs.molpharmaceut.2c00411.

Related products

  • Actin Mouse Monoclonal Antibody

    Actin Mouse Monoclonal Antibody

    This product is a β-actin mouse monoclonal antibody prepared using a synthetic peptide of N-terminal β-actin as antigen. The clone number is AC-74. This Actin antibody recognizes only β-actin in Western blot or immunostaining analysis. Package: 40T

  • Actin-Tracker Red-555

    Actin-Tracker Red-555

    Actin-Tracker Red-555 is a red fluorescent probe that specifically binds and labels filamentous actin (F-actin) in cultured cells or tissue sections. Package: 0.2ml

  • Akt Rabbit Polyclonal Antibody

    Akt Rabbit Polyclonal Antibody

    This product is a high-purity polyclonal antibody obtained by immunizing rabbit with a synthetic mouse Akt C-terminal segment with appropriate modifications and then purified in two steps using protein A and antigen peptide affinity chromatography. Package：10T, 10ul

  • Alexa Fluor 488-labeled Goat Anti-Mouse IgG(H+L)

    Alexa Fluor 488-labeled Goat Anti-Mouse IgG(H+L)

    AF488-labeled Goat Anti-Mouse IgG (H+L) is a secondary antibody for immunofluorescence staining. Package: 100ul

  • Alexa Fluor 488-labeled Goat Anti-Rabbit IgG(H+L)

    Alexa Fluor 488-labeled Goat Anti-Rabbit IgG(H+L)

    AF488-labeled Goat Anti-Rabbit IgG (H+L) is a secondary antibody for immunofluorescence staining. Alexa Fluor (AF) dyes, trademarked by Molecular Probes, are advanced fluorescent dyes derived from Coumarin, Rhodamine, Xanthene, and Cyanine via sulfonation and chemical modification (e.g., Alexa Fluor 488, or AF488). Package: 100ul

Please enter your email address to receive your cart as a PDF.